Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2026-05-24 @ 11:33 AM
Study NCT ID:
NCT00240994
Status:
COMPLETED
Last Update Posted:
2017-01-02
First Post:
2005-10-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
DAIT PC01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NETWORK | View |